期刊文献+

单核细胞/淋巴细胞比值与呼吸系统疾病评估相关性的研究进展 被引量:10

Research Progress in Correlation between Monocyte/Lymphocyte Ratio and Assessment of Respiratory Diseases
下载PDF
导出
摘要 单核细胞/淋巴细胞比值(MLR)是近年来备受关注的新型炎症指标,其反映了外周血中单核细胞与淋巴细胞之间的动态平衡,也可直接反映机体炎症状态,在许多呼吸系统疾病(如社区获得性肺炎、慢性阻塞性肺疾病、肺癌)中MLR均有升高,且MLR的水平可用于评估呼吸系统疾病严重程度、临床治疗效果、预测疾病预后情况等。进一步探索MLR在呼吸系统疾病中的作用,可为呼吸系统疾病的诊断及治疗提供更加便捷的生物学指标,为呼吸系统疾病的早期诊断提供依据。 Monocyte/lymphocyte ratio(MLR)is a new type of inflammation index that has attracted much attention in recent years.It reflects the dynamic balance between monocytes and lymphocytes in the peripheral blood,which can also directly reflect the body′s inflammatory state.In many system diseases(such as community-acquired pneumonia,chronic obstructive pulmonary disease,lung cancer)the level of MLR is elevated,which can be used to assess the severity,clinical treatment effects,and predict disease prognosis of respiratory diseases.Further exploration of the role of MLR in respiratory diseases can provide more convenient biological indicators for the diagnosis and treatment of respiratory diseases,and provide a basis for the early diagnosis.
作者 王梦瑶 张薇 郭友芳 冯明发 WANG Mengyao;ZHANG Wei;GUO Youfang;FENG Mingfa(Department of Respiratory and Critical Care Medicine,the First Affiliated Hospital of Harbin Medical University,Harbin 150001,China)
出处 《医学综述》 CAS 2021年第15期3045-3049,共5页 Medical Recapitulate
基金 哈尔滨医科大学附属第一医院科研创新基金计划(2020YJ01)。
关键词 呼吸系统疾病 单核细胞/淋巴细胞比值 慢性阻塞性肺疾病 肺癌 社区获得性肺炎 Respiratory diseases Monocyte/lymphocyte ratio Chronic obstructive pulmonary disease Lung cancer Community-acquired pneumonia
  • 相关文献

参考文献9

二级参考文献66

  • 1叶松道,苏士海,陶洪群.支气管哮喘患儿血小板5项参数检测的临床意义[J].临床检验杂志,2005,23(3):222-222. 被引量:7
  • 2陆权.儿童社区获得性肺炎管理指南(试行)(上)[J].中华儿科杂志,2007,45(2):83-90. 被引量:602
  • 3Gershon AS, Warner L, Cascagnette P, et al. Lifetime risk of developing chronic obstructive pulmonary disease: a longitudinal population study [ J ]. Lancet, 2011, 378 (9795) : 991-996.
  • 4Demoly P, Annunziata K, Gubba E, et al. Repeated cross-sectional survey of patient-reported asthma control in Europe in the past 5 years[J]. Eur Respir Rev, 2012, 21(23) : 66-74.
  • 5Peters SP, Jones CA, Affiliations Division of Allergy and Immunology,Department of Pediatrics, Los Angeles County and University of Southem California Medical Center, Los AngelesHaselkom T, et al. Real-world Evaluation of Asthma Control and Treatment (REACT) : Findings from a national Web-based survey [ J ]. J Allergy ClinImmunol, 2007, 119(6) : 1454-1461.
  • 6Boulet LP, FitzGerald JM, Levy ML, etal. A guide to the translation of the Global Initiative for Asthma ( GINA ) strategy into improved care[J]. Eur Respir J, 2012, 39(5) : 1220-1229.
  • 7Haahtela T, Tuomisto LE, Pietinalho A, etal. A 10 year asthma programme in Finland : major change for the better [ J ]. Thorax, 2006, 61(8) : 663-670.
  • 8Green RH, Brighfling CE, McKenna S, et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial [ J ]. Lancet, 2002, 360(9347): 1715-1721.
  • 9Powell H, Murphy VE, Taylor DR, et al. Management of asthma in preguancy guided by measurement of fraction of exhaled nitric oxide: a double-blind, randomised controlled trial[ J ]. Lancet, 2011,378 (9795) : 983-990.
  • 10儿童支气管哮喘诊断与防治指南[J].中华儿科杂志,2008,46(10):745-753. 被引量:2511

共引文献134

同被引文献90

引证文献10

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部